APA (7th ed.) Citation

TO, B., JL, R., RE, P., L, G., JP, L., EY, K., . . . AR, S. (2018). Genome-wide and candidate gene approaches of clopidogrel efficacy using pharmacodynamic and clinical end points-Rationale and design of the International Clopidogrel Pharmacogenomics Consortium (ICPC). American heart journal, 198, 152. https://doi.org/10.1016/j.ahj.2017.12.010

Chicago Style (17th ed.) Citation

TO, Bergmeijer, et al. "Genome-wide and Candidate Gene Approaches of Clopidogrel Efficacy Using Pharmacodynamic and Clinical End Points-Rationale and Design of the International Clopidogrel Pharmacogenomics Consortium (ICPC)." American Heart Journal 198 (2018): 152. https://doi.org/10.1016/j.ahj.2017.12.010.

MLA (9th ed.) Citation

TO, Bergmeijer, et al. "Genome-wide and Candidate Gene Approaches of Clopidogrel Efficacy Using Pharmacodynamic and Clinical End Points-Rationale and Design of the International Clopidogrel Pharmacogenomics Consortium (ICPC)." American Heart Journal, vol. 198, 2018, p. 152, https://doi.org/10.1016/j.ahj.2017.12.010.